Clinical Trial Update: Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that Phase 1 and Phase 2 studies evaluating immunotherapy after chemotherapy in men with hormone-refractory metastatic prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Washington | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED